Real-time enrollment status for this relapsed/refractory acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:08 PM UTC
| NCT Number | NCT06549790 |
| Recruiting Status | Recruiting |
| Condition | Relapsed/Refractory Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 124 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Nerviano Medical Sciences |
| Last Updated on CT.gov | October 31, 2025 (Oct 31, 2025) |
As of July 13, 2026: Clinical trial NCT06549790 is currently recruiting participants. This clinical trial study for relapsed/refractory acute myeloid leukemia is actively seeking new participants at 7 locations across the United States. The study is sponsored by Nerviano Medical Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06549790 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06549790 was last updated Oct 31, 2025 (October 31, 2025). HelloStudys verifies this status automatically.